Defective Wnt signaling: A potential contributor to cardiometabolic disease?

Diabetes

Volumn 64, Issue 10, 2015, Pages 3342-3344

  Arnold, Amy C ^a   Robertson, David ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DISHEVELLED PROTEIN; FRIZZLED PROTEIN; INSULIN; INSULIN RECEPTOR SUBSTRATE 1; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN 6; NITRIC OXIDE; TRANSCRIPTION FACTOR 7 LIKE 2; GLYCOGEN SYNTHASE KINASE 3; INSULIN RECEPTOR SUBSTRATE; WNT PROTEIN;

BLOOD PRESSURE REGULATION; BRAIN STEM; CARDIOVASCULAR DISEASE; CENTRAL NERVOUS SYSTEM; CHOLESTEROL METABOLISM; DOWN REGULATION; ENERGY EXPENDITURE; HEART RATE; HEART VENTRICLE HYPERTROPHY; HYPERTENSION; INSULIN SENSITIVITY; KIDNEY INJURY; METABOLIC DISORDER; METABOLIC REGULATION; MOLECULAR BIOLOGY; NERVE TRACT; NONHUMAN; NOTE; PLEIOTROPY; PRIORITY JOURNAL; PROADIPOCYTE; PROTEIN PHOSPHORYLATION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SOLITARY TRACT NUCLEUS; SYSTOLIC BLOOD PRESSURE; WNT SIGNALING PATHWAY; ANIMAL; BLOOD PRESSURE; MALE; METABOLISM; PHYSIOLOGY;

ANIMALS; BLOOD PRESSURE; GLYCOGEN SYNTHASE KINASE 3; INSULIN; INSULIN RECEPTOR SUBSTRATE PROTEINS; MALE; SOLITARY NUCLEUS; WNT PROTEINS;

EID: 84953319726     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db15-0822     Document Type: Note

References (19)

1. Nwankwo T, Yoon SS, Burt V, Gu Q. Hypertension among adults in the United States: National Health and Nutrition Examination Survey, 2011-2012. NCHS Data Brief 2013; 133:1-8
2. Moon RT, Bowerman B, Boutros M., Perrimon N. The promise and perils of Wnt signaling through beta-catenin. Science 2002; 296:1644-1646
3. Guo YF, Xiong DH, Shen H, et al Polymorphisms of the low-density lipoprotein receptor-related protein 5 (LRP5) gene are associated with obesity phenotypes in a large family-based association study. J Med Genet 2006; 43: 798-803
4. Mani A, Radhakrishnan J, Wang H., et al. LRP6 mutation in a family with early coronary disease and metabolic risk factors. Science 2007; 315:1278-1282
5. Singh R, Smith E, Fathzadeh M., et al. Rare nonconservative LRP6 mutations are associated with metabolic syndrome. Hum Mutat 2013; 34:1221-1225
6. Singh R, De Aguiar RB, Naik S, et al. LRP6 enhances glucose metabolism by promoting TCF7L2-dependent insulin receptor expression and IGF receptor stabilization in humans. Cell Metab 2013; 17:197-209
7. Grant SF, Thorleifsson G, Reynisdottir I., et al. Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat Genet 2006; 38:320-323
8. Elghazi L, Gould AP, Weiss A.J., et al. Importance of β-catenin in glucose and energy homeostasis. Sci Rep 2012; 2:693
9. Fujino T, Asaba H, Kang M.J., et al. Low-density lipoprotein receptor-related protein 5 (LRP5) is essential for normal cholesterol metabolism and glucose-induced insulin secretion. Proc Natl Acad Sci U S A 2003; 100:229-234
10. Liu W, Singh R, Choi C.S., et al. Low density lipoprotein (LDL) receptor-related protein 6 (LRP6) regulates body fat and glucose homeostasis by modulating nutrient sensing pathways and mitochondrial energy expenditure. J Biol Chem 2012; 287:7213-7223
11. Liu Z, Habener JF Wnt signaling in pancreatic islets. Adv Exp Med Biol 2010; 654:391-419
12. Cheng P-W, Chen Y-Y, Cheng W-H, et al. Wnt signaling regulates blood pressure by downregulating a GSK-3b-mediated pathway to enhance insulin signaling in the central nervous system. Diabetes 2015; 64:3413-3424
13. Abiola M, Favier M, Christodoulou-Vafeiadou E, Pichard A.L., Martelly I., Guillet-Deniau I. Activation of Wnt/beta-catenin signaling increases insulin sensitivity through a reciprocal regulation of Wnt10b and SREBP-1c in skeletal muscle cells. PLoS One 2009; 4:e8509
14. Palsgaard J, Emanuelli B, Winnay J.N., Sumara G., Karsenty G, Kahn CR. Cross-talk between insulin and Wnt signaling in preadipocytes: role of Wnt coreceptor low density lipoprotein receptor-related protein-5 (LRP5). J Biol Chem 2012; 287:12016-12026
15. Hwang I, Seo EY, Ha H. Wnt/beta-catenin signaling: a novel target for therapeutic intervention of fibrotic kidney disease. Arch Pharm Res 2009; 32: 1653-1662
16. van de Schans VA, Smits JF, Blankesteijn WM The Wnt/frizzled pathway in cardiovascular development and disease: friend or foe? Eur J Pharmacol 2008; 585:338-345
17. Shan Z, Shi P, Cuadra A.E., et al. Involvement of the brain (pro)renin receptor in cardiovascular homeostasis. Circ Res 2010; 107:934-938
18. Balakumar P, Jagadeesh G. Potential cross-talk between (pro)renin receptors and Wnt/frizzled receptors in cardiovascular and renal disorders. Hypertens Res 2011; 34:1161-1170
19. Zhou L, Li Y, Hao S., et al. Multiple genes of the renin-angiotensin system are novel targets of Wnt/b-catenin signaling. J Am Soc Nephrol 2015; 26: 107-120